Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms’ Tumor

Table 1

The top 10 differentially expressed mRNAs.

mRNA	log FC	log CPM	value	FDR
Upregulated
SOX11	8.24369	8.12664	1.31E − 52	1.18E − 50
EYA1	9.12925	8.5296	8.96E − 51	7.51E − 49
NUSAP1	4.86672	7.60798	3.05E − 48	2.27E − 46
SIX1	8.88707	6.71694	4.02E − 45	2.77E − 43
TOP2A	5.54746	8.95599	5.97E − 44	3.91E − 42
COL2A1	10.5667	9.52236	1.00E − 43	6.53E − 42
APBA2	4.80478	5.88552	3.24E − 43	2.05E − 41
ARHGAP11A	4.48895	5.94823	3.83E − 43	2.42E − 41
ELOVL2	7.89597	5.7256	1.45E − 42	8.97E − 41
SIX2	12.5161	9.1566	1.20E − 41	7.12E − 40
Downregulated
CLCNKA	−10.252	3.96865	2.05E − 202	3.78E − 198
MFSD4A	−6.5728	3.94457	1.29E − 200	1.19E − 196
SLC4A1	−8.7927	2.31542	2.03E − 196	1.25E − 192
AQP2	−13.939	7.07934	8.09E − 192	3.73E − 188
GCNT3	−7.5293	1.16448	6.64E − 186	2.45E − 182
PTGER1	−7.3274	2.50008	5.04E − 173	1.55E − 169
RASD1	−7.4598	5.22617	4.15E − 167	1.09E − 163
CLCNKB	−7.8428	3.94067	1.29E − 158	2.97E − 155
SLC4A9	−6.7956	-0.12053	2.48E − 153	5.08E − 150
BSND	−10.059	1.11375	4.06E − 151	7.49E − 148

mRNAs, messenger RNAs; FC, fold change; FDR, false discovery rate; CPM, counts per million.